NCT03159702 · OUTCOME

Nonrelapse Mortality Rate.

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation · Source last updated 2026-01-27

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: 1 Year

What was measured

This is the number of participants expiring without recurrent or progressive disease after transplantation.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

anticipated Posting Date: 2026-12
denom Units Selected: Participants
description: This is the number of participants expiring without recurrent or progressive disease after transplantation.
reporting Status: NOT_POSTED
time Frame: 1 Year
title: Nonrelapse Mortality Rate.
type: SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice